Geneos Wealth Management’s Royal Caribbean RCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $374K | Sell |
1,358
-82
| -6% | -$24.4K | 0.01% | 779 |
|
|
2025
Q4 | $402K | Hold |
1,440
| – | – | 0.01% | 731 |
|
|
2025
Q3 | $466K | Sell |
1,440
-650
| -31% | -$217K | 0.01% | 670 |
|
|
2025
Q2 | $654K | Sell |
2,090
-1,244
| -37% | -$296K | 0.02% | 633 |
|
|
2025
Q1 | $880K | Sell |
3,334
-13,897
| -81% | -$3.28M | 0.01% | 704 |
|
|
2024
Q4 | $3.98M | Sell |
17,231
-1,047
| -6% | -$232K | 0.14% | 170 |
|
|
2024
Q3 | $3.24M | Buy |
18,278
+4
| +0% | +$648 | 0.12% | 199 |
|
|
2024
Q2 | $2.91M | Sell |
18,274
-509
| -3% | -$73.2K | 0.13% | 187 |
|
|
2024
Q1 | $2.61M | Sell |
18,783
-62
| -0.3% | -$7.74K | 0.12% | 208 |
|
|
2023
Q4 | $2.44M | Buy |
18,845
+17,782
| +1,673% | +$1.81M | 0.12% | 201 |
|
|
2023
Q3 | $97.9K | Hold |
1,063
| – | – | 0.01% | 877 |
|
|
2023
Q2 | $110K | Hold |
1,063
| – | – | 0.01% | 849 |
|
|
2023
Q1 | $69.4K | Hold |
1,063
| – | – | ﹤0.01% | 965 |
|
|
2022
Q4 | $52.5K | Hold |
1,063
| – | – | ﹤0.01% | 1040 |
|
|
2022
Q3 | $40K | Sell |
1,063
-797
| -43% | -$32.3K | ﹤0.01% | 1094 |
|
|
2022
Q2 | $65K | Hold |
1,860
| – | – | ﹤0.01% | 1173 |
|
|
2022
Q1 | $155K | Sell |
1,860
-330
| -15% | -$26K | 0.01% | 906 |
|
|
2021
Q4 | $168K | Sell |
2,190
-378
| -15% | -$30.7K | 0.01% | 945 |
|
|
2021
Q3 | $237K | Buy |
2,568
+60
| +2% | +$4.85K | 0.01% | 791 |
|
|
2021
Q2 | $215K | Sell |
2,508
-540
| -18% | -$47.1K | 0.01% | 811 |
|
|
2021
Q1 | $265K | Sell |
3,048
-100
| -3% | -$7.93K | 0.01% | 851 |
|
|
2020
Q4 | $250K | Sell |
3,148
-566
| -15% | -$39.5K | 0.01% | 753 |
|
|
2020
Q3 | $239K | Sell |
3,714
-182
| -5% | -$10.7K | 0.01% | 630 |
|
|
2020
Q2 | $180K | Buy |
3,896
+1,952
| +100% | +$88.3K | 0.01% | 702 |
|
|
2020
Q1 | $67K | Buy |
1,944
+1,314
| +209% | +$120K | ﹤0.01% | 997 |
|
|
2019
Q4 | $84K | Buy |
630
+1
| +0.2% | +$117 | ﹤0.01% | 1018 |
|
|
2019
Q3 | $67K | Sell |
629
-30
| -5% | -$3.3K | ﹤0.01% | 1050 |
|
|
2019
Q2 | $79K | Sell |
659
-33
| -5% | -$4.02K | ﹤0.01% | 999 |
|
|
2019
Q1 | $79K | Buy |
692
+1
| +0.1% | +$114 | 0.01% | 948 |
|
|
2018
Q4 | $66K | Hold |
691
| – | – | ﹤0.01% | 982 |
|
|
2018
Q3 | $89K | Sell |
691
-1
| -0.1% | -$117 | 0.01% | 929 |
|
|
2018
Q2 | $71K | Sell |
692
-1
| -0.1% | -$110 | 0.01% | 904 |
|
|
2018
Q1 | $81K | Hold |
693
| – | – | 0.01% | 826 |
|
|
2017
Q4 | $82K | Buy |
693
+30
| +5% | +$3.71K | 0.01% | 813 |
|
|
2017
Q3 | $78K | Hold |
663
| – | – | 0.01% | 785 |
|
|
2017
Q2 | $72K | Sell |
663
-10
| -1% | -$1.06K | 0.01% | 792 |
|
|
2017
Q1 | $66K | Buy |
673
+306
| +83% | +$28.6K | 0.01% | 791 |
|
|
2016
Q4 | $30K | Hold |
367
| – | – | ﹤0.01% | 1025 |
|
|
2016
Q3 | $27K | Buy |
367
+32
| +10% | +$2.25K | ﹤0.01% | 1027 |
|
|
2016
Q2 | $23K | Hold |
335
| – | – | ﹤0.01% | 1073 |
|
|
2016
Q1 | $27K | Buy |
+335
| New | +$26.1K | ﹤0.01% | 1001 |
|
Other funds holding RCL
VCM
VPM
Geneos Wealth Management's RCL Position: Q1 2026 in Review
Geneos Wealth Management reduced its Royal Caribbean (RCL) stake by 5.7% in Q1 2026, selling an estimated $24.4K and leaving 1,358 shares worth $374K. The position accounts for 0.01% of the portfolio, ranked #779.
Geneos Wealth Management first reported a position in RCL in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.98M in Q4 2024. 1,169 funds tracked by Wall St. Rank hold RCL as of Q1 2026.
- Geneos Wealth Management held 1,358 shares of Royal Caribbean worth $374K as of Q1 2026.
- Geneos Wealth Management sold 82 Royal Caribbean shares in Q1 2026, an estimated $24.4K.
- Royal Caribbean made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #779 holding.
- Geneos Wealth Management first reported a position in Royal Caribbean in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Royal Caribbean position peaked at $3.98M in Q4 2024.
- 1,169 funds tracked by Wall St. Rank held Royal Caribbean as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.